Onyx Scientific Announces Facility Expansion
PTSM: Pharmaceutical Technology Sourcing and Management
Planned expansion at Onyx Scientific add laboratories, GMP suites, and storage space.
Onyx Scientific, a UK-based contract research organization and and small-scale API manufacturer, has announced an investment in an additional site located adjacent to its existing facility in North-East England to increase its laboratory facilities, GMP suites, and storage of GMP materials. In addition, the company has recruited several more chemists to support clients’ pre-clinical, development, and early-stage API manufacturing projects.
In 2015, the company grew its GMP space following an increase in demand for its small-scale API manufacturing services, according to a Jan. 28, 2016 press statement.
Established in 2000, the company provides clients with the production of API in up to 50 L–100 L equipment under current GMP regulations, and also offers earlier stage custom synthesis, lead optimization, and analytical services.
Source: Onyx Scientific
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
